Omeros (OMER) PT Raised to $32 at Needham & Company Into Spring U.S. Launch of Omidria

Go back to Omeros (OMER) PT Raised to $32 at Needham & Company Into Spring U.S. Launch of Omidria

Omeros (OMER) PT Lifted to $54 at Wedbush

March 17, 2015 7:17 AM EDT

Wedbush analyst Liana Moussatos reiterated an Outperform rating and boosted her price target on Omeros Corp. (NASDAQ: OMER) to $54.00 (from $52.00) following in-line Q4 results.

Moussatos notes OMIDRIA is scheduled for launch in early April and the next potential catalysts is potential CHMP... More

Omeros (OMER) Tops Q4 EPS by 1c

March 16, 2015 4:06 PM EDT

Omeros (NASDAQ: OMER) reported Q4 EPS of ($0.61), $0.01 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $180 thousand versus the consensus estimate of $90 thousand.

For earnings history and earnings-related data on Omeros (OMER) click here.

... More